Skip to main content
. 2007 Oct 17;104(43):17040–17045. doi: 10.1073/pnas.0705894104

Fig. 4.

Fig. 4.

Overlapping prevalence of ZnT8A, GADA, IA2A, and IAA at onset. (A) Seropositive individuals evaluated with three-autoantibody standard or with ZnT8A substituted for GADA, IA2A, or IAA. The ZnT8A assay incorporates both C-terminal and N/C assays in the one measurement. (B) Seropositive individuals evaluated with four-autoantibody standard.